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Abstract
Background: Oral squamous cell carcinoma (OSCC) is becoming more common across the globe. The prognosis of
OSCC is largely dependent on the early detection. But the routine oral cavity examination may delay the diagnosis
because the early oral malignant lesions may be clinically indistinguishable from benign or inflammatory diseases.
In this study, the new diagnostic method is developed by using the surface enhanced Raman spectroscopy (SERS)
to detect the serum samples from the cancer patients.
Method: The blood serum samples were collected from the OSCC patients, MEC patients and the volunteers
without OSCC or MEC. Gold nanoparticles(NPs) were then mixed in the serum samples to obtain the high quality
SERS spectra. There were totally 135 spectra of OSCC, 90 spectra of mucoepidermoid carcinoma (MEC) and 145
spectra of normal control group, which were captured by SERS successfully. Compared with the normal control
group, the Raman spectral differences exhibited in the spectra of OSCC and MEC groups, which were assigned to
the nucleic acids, proteins and lipids. Based on these spectral differences and features, the algorithms of principal
component analysis(PCA) and linear discriminant analysis (LDA) were employed to analyze and classify the Raman
spectra of different groups.
Results: Compared with the normal groups, the major increased peaks in the OSCC and MEC groups were
assigned to the molecular structures of the nucleic acids and proteins. And these different major peaks between
the OSCC and MEC groups were assigned to the special molecular structures of the carotenoids and lipids. The
PCA-LDA results demonstrated that OSCC could be discriminated successfully from the normal control groups with
a sensitivity of 80.7% and a specificity of 84.1%. The process of the cross validation proved the results analyzed by
PCA-LDA were reliable.
Conclusion: The gold NPs were appropriate substances to capture the high-quality SERS spectra of the OSCC, MEC
and normal serum samples. The results of this study confirm that SERS combined PCA-LDA had a giant capability to
detect and diagnosis OSCC through the serum sample successfully.
Keywords: Oral squamous cell carcinoma (OSCC), Surface-enhanced Raman spectroscopy (SERS), Principal
component analysis (PCA), Linear discriminant analysis(LDA), Diagnosis
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Background
Oral squamous cell carcinoma (OSCC) is among the
10th most common cancer in the world, and the annual
incidence of OSCC continues to increase specifically in
Western and Asian countries [1, 2]. It is reported 3.29
per 100,000 as incidence rate and 1.49 per 100,000 as
mortality rate in China [3]. The survival of OSCC is
poor, with a 5-years survival rate of approximately 50%
and has not a remarkable improve in the recent decades.
The early detection by screening can be considered the
best method to improve survival [4]. However the oral
cavity is accessible to physical examination, the clinical
visual examinations occasionally may delay the diagnosis
because the early oral malignant lesions may be clinically
indistinguishable from benign or inflammatory diseases
[5]. The reliability of visual examination is also question-
able and there are insufficient evidence to recommend a
visual examination in screening for oral cancer in a low-
risk population [5, 6]. The oral biopsy is considered the
golden standard of OSCC diagnosis, but it is time con-
suming, labor intensive and invasive [7]. So a real-time,
accurate and non-invasive diagnostic method is a press-
ing need for OSCC detection.
The surface-enhanced Raman spectroscopy (SERS)
was first discovered by Fleichman and his colleages who
founded the Raman intensities were enhanced as much
as 105–1014 times by adsorbing molecules onto nano-
structured metal surfaces [8–10]. SERS can overcome
the drawbacks of regular Raman spectroscopy such as
weak Raman intensities and strong autofluorescence
background, and make the possibility of detecting trace
or even single molecule. The SERS have been applied
successfully on the detection of oncological diseases in
different sites [11]. The key point of successful diagnosis
by Raman spectroscopy is the dependence on the visual
detection of morphologically or structurally aberrant le-
sions [2]. But the early oral carcinoma may be visually
indistinguishable due to the subtle morphological alter-
ations, and the Raman spectroscopic technique can not
focus exactly on the lesions which could result in the
false diagnosis. And some OSCC arising on the hidden
sites in oral cavity such as the tongue base are not easy
to be diagnosed at the early stage. So the spectral detec-
tion and analysis of biofluids using SERS is considered a
novel, non-invasive and convenient method for the
OSCC diagnosis. A systematic study based on the SERS
of blood plasma and serum recommends the serum as
the sample of choice due to the interference of anticoag-
ulants in common plasma and various pathological me-
tabolites in patients’ serums [12]. In our previous study,
SERS combined with support vector machine has suc-
cessfully distinguished the patients with different parotid
gland tumors from the normal subjects by detecting the
blood serums [10]. So in this study, we developed the
method of blood serum detection by using SRES based
on gold nanoparticles to diagnose the OSCC.
Methods
Subjects and protocol
In this study, a total of 135 patients with OSCC were
selected as the experimental group, who were not
treated prior to this study and didn’t have any other sys-
metic diseases or drug abuse. In order to demonstrate
the ability of discrimination of the method, 90 patinets
with the mucoepidermoid carcinoma (MEC) were
selected as the positive control group. And a total of 145
patients with old maxillofacial fracture and healthy vol-
unteers were selected as the normal control group. More
information on the subjects was shown in Table 1. At
the beginning of the study, all subjects were informed
detailedly and gave their written informed consents. The
routine blood examinations of all subjects remained in
the normal range. And this study was approved by the
Ethics Committees of the First Affiliated Hospital of Xia-
men University and followed the guidelines of the
Helsinki Declaration.
Preparation of the gold nanoparticles
Gold nanoparticles(NPs) were prepared through the de-
oxidizing process reported in the our previous study [9].
A total of 0.7 ml of 1% w/v trisodiumcitric acid was
added rapidly in the beaker of rolling boiled 100 ml
HAuCl4. The mixed solution was heated to keep boiling
and stirred continuously for half hours. The golden NPs
were produced when the color of the solution changed
from pale yellow to burgundy. The experimental condi-
tions of different batches were controlled very carefully
to guarantee the consistency of the shape and volume of
the gold NPs. The gold NPs solution was stored at 4 °C
for the SERS measurement.
Preparation of blood serum samples
A total of 5 ml peripheral blood sample was obtained
from the subject who had fasted overnight for 10 h. The
obtained blood sample was deposited at 4 °C for 4 h




Age rang 39–70 28–79 18–68
Median age 58 44 36
Gender
Male 75 50 93
Female 60 40 52
Total 135 90 145
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without any anticoagulant. Then the blood sample was
centrifuged at 3400 rpm for 10 mins in order to remove
the cells, fibrinogen and platelet in the blood. A single
1 ml supernatant serum sample was collected from the
centrifuged blood and stored at −20 °C the Raman
detection.
Scanning electron microscopy (SEM) and the ultraviolet-
visible spectroscopy analysis
The morphologies of the gold NPs were detected by
using a scanning electron microscope (HITACHI S-
4800, Hitachi Ltd., Tokyo, Japan) with a voltage of
30 kV. The absorption of the gold NPs and the mixture
of the serum and gold NPs were monitored by the
ultraviolet-visible spectroscope (Cary5000, VARIAN Ltd.,
USA).
SERS measurement
A total 4 ml of gold NPs solution prepared in the above
processing was added into a tube and centrifuged at
6000 rpm for 10mins. Then the supernatant was discarded
from the gold NPs and a 0.4 ml serum sample was added
for the SERS measurement. The mixed solution was
vibrated by ultrasonic oscillator in order to make the NPs
distribute more homogeneously. The solution was incu-
bated at 4 °C for 2hs before the SERS measurement. The
SERS measurement was carried out by using a Renishaw
inVia Raman microscope (Renishaw Ltd., UK) with a
633 nm laser. The excitation laser with a power of about
0.4 W was focused on the serum samples through a ×50
objective lens (NA = 0.75). The spectra were recorded in
the 200–1800 cm−1 Raman shift range with a 2 cm−1 spec-
tral resolution. Every spectrum was integrated for 10s and
averaged over 2 accumulations.
Data pre-processing
Before the data statistical analysis, the raw Raman spec-
tral data were preprocessed by WiRE 2.0 software
(Renishaw Ltd., UK) to remove the noisy interferences
and oversaturated spectra. The autofluorescence back-
grounds were removed by the 4th degree polynomial
function and the SERE spectra were smoothed by the
Savitzky-Golay smoothing through the LABSPEC 2.0
software (HORIBA Scientific, France). Then the baseline
correction and normalization were carried out before
the further analysis and comparison of the different
spectra.
The mean spectra of different groups were obtained by
calculating and analyzing the pre-processed data through
the OringinPro 8.0 software (OringinLab, USA). The
spectral differences between the groups were obtained
by subtracting the mean spectra of different groups. The
differences of peaks shown in the subtracted spectra
were assigned to the molecular structures and
biochemical component based on the results reported in
the previous literatures.
Multivariate analysis
Principal component analysis(PCA) was employed to
reduce the dimensions and determine the key variables.
In this study, the retaining principal components which
accounted for 90% of the variance in the spectral data
was applied as statistical variables and input into Linear
discriminant analysis(LDA) for the serum classification.
The prediction performance of the diagnostic model
rendered by LDA was estimated and evaluated by the
leave-one-out-cross-validation method. This study
discriminated the OSCC group from the normal group
firstly, and then discriminated the OSCC group from the
MEC group and the normal group.
Results
The SEM image of the pure gold NPs was shown in the
Fig. 1a. The spherical NPs with a mean diameter of
55 nm were prepared in this method and had a maximal
absorption at 530 nm. In the UV-visible absorption spec-
tra shown in Fig. 1b, the pure NPs solution absorption
band appeared in the around 530 nm wavelength region,
and the band of the mixture of serum and NPs also
remained in the same region but the intensity reduced
due to the combination of gold NPs and biochemical
substances in the serum. Compared with the regular
Raman spectrum, the intensities of the SERS spectrum
were enhanced enormously due to the gold NPs added
in the serum (Fig. 1c).
A total of 370 SERS spectra were recorded successfully
in the Raman shift region from 200 cm−1 to 1800 cm−1.
Among these spectra, 135 spectra were obtained from
the clinically confirmed OSCC subjects, 90 spectra were
obtained from the clinically confirmed MEC subjects
and 145 spectra were obtained from the normal control
subjects. The clinical data of the subjects participating in
this study was shown in the Table 1. The mean spectra
of different groups before the spectral normalization
were presented in the Fig. 2. And after the spectral
normalization, the normalized mean spectra were used
to compare the spectral differences of the OSCC, MEC
and normal groups (Fig. 3). Compared with the mean
spectrum of the normal control group, the OSCC group
showed the increase in the peaks at 294, 446, 548, 726,
745, 1136, 1263, 1371, 1445 and 1491 cm−1 but the de-
crease in the peaks at 1542 and 1602 cm−1, which were
shown in the subtracted spectrum (Fig. 4a). Compared
with the mean spectrum of the normal control group,
the MEC group showed the increase in the peaks at 476,
548, 726, 745, 933, 1328, 1371 and 1445 cm−1 but the
decrease in the peaks at 294, 1263, 1541 and 1607 cm−1
(Fig. 4b). The spectral differences were also presented in
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the subtracted spectrum between the OSCC group and
MEC group. The subtracted spectrum showed the
increase in the peaks at 294,1139,1263 and 1491 cm−1
but the decrease in the peaks at 1602 cm−1 in the OSCC
group compared with the MEC group (Fig. 4c).
All these peaks of different intensities shown in the
subtracted spectrum can be assigned to the various
biochemical substances and molecular structures
according to the reported literatures and previous stud-
ies [9, 13–18] (Table 2). Compared with the normal
groups, the major increased peaks in the OSCC and
MEC groups were assigned to the molecular structures
of the nucleic acids and proteins. And these different
major peaks between the OSCC and MEC groups were
Fig. 2 The average Raman spectra of OSCC, MEC and normal serum samples. The gray areas manifest the standard deviations
Fig. 1 The SEM image, absorption curve and Raman spectrum of the gold NPs. a The SEM image of the gold NPs. b The UV/visible absorption of
the gold NPs and the gold NPs with serum. c SERS spectrum of serum, routine Raman spectrum of serum and background Raman spectrum of
the gold NPs
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assigned to the special molecular structures of the carot-
enoids and lipids. The diagnostic classification of the dif-
ferent spectra can be carried out based on these peaks
reported above.
In the first analytical step to discriminate the OSCC
spectra from the normal ones, the OSCC spectra were
selected as the positive group and the normal ones were
selected as the negative group. The process of PCA
extracted 55 principle components(PCs) from the raw
spectral data, which captured about 95% of the cumula-
tive variance of the raw data and were input as variables
for the LDA process. As the result of the LDA, 109 of
135 OSCC spectra and 122 of 145 normal spectra were
classified into the accurate group successfully (Table 3).
The sensitivity and specificity were 80.7 and 84.1%
respectively, and the total accuracy of this diagnostic
classification was 82.5%. The histogram of discrimin-
ation scores demonstrated a clear classification of the
two groups (Fig. 5). In order to test the results of the
classification, the ‘leave-one-out’ method was employed
in the cross validation process. And the result of the
cross validation shown that 107/135 of OSCC spectra
and 120/145 of normal spectra were diagnosed correctly
(Table 4). The sensitivity and specificity of the diagnosis
were 79.3 and 82.8%, and the total accuracy was 81.1%.
In order to demonstrate the potential more effectively to
diagnose the OSCC by SERS, the MEC spectra were
selected as the positive control group in the diagnostic clas-
sification. The PCA process also extracted 51 PCs from the
raw data, which accounted for about 93% of the total vari-
ance. Then the PCs were input in the LDA process to clas-
sify the three different groups. The result shown that 101/
135 of OSCC spectra, 72/90 of MEC spectra and 129/145
of normal spectra were classified into the correct groups
successfully (Table 5). The sensitivity and specificity of the
diagnosis of OSCC were 74.8 and 89.0%, and the total
accuracy was 81.6%. The scatter plot diagram showed the
separation of the three groups (Fig. 6). Then the ‘leave-one-
out’ method was employed in the cross validation process
to test the results of the classification. In the results of the
cross validation, 82/135 of OSCC spectra were classified
correctly, 64/90 of MEC spectra and 109/145 of normal
spectra were also diagnosed correctly. The sensitivity and
specificity of the diagnosis of OSCC were 60.7 and 75.2%,
and the total accuracy was 68.9% (Table 6).
Discussion
The American Academy of Oral Medicine recognized
that the patients with oral cancer detected in the early
Fig. 3 The normalized mean Raman spectra of OSCC, MEC and
normal serum samples
Fig. 4 The subtracted spectra of the OSCC, MEC and normal
serum samples
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stages required less aggressive treatment and experi-
enced fewer complications than the ones with advanced
stage cancers, and the patients with early stage oral can-
cer would have improved survival [19]. And the evidence
existed in a systematic review that the development and
use of biomarkers was becoming increasingly common
in the early detection of oral cancer [20]. The metabo-
lites in the biofluids of the patients with cancers are dif-
ferent from the normal subjects, due to the amino acid
metabolism, cell apoptosis and tumor necrosis, which
can be used for the cancer detection as the biomarkers
[10, 12]. The serum or plasma have been selected as the
samples for the cancer detection and diagnosis by
Raman spectroscopy successfully because the serum or
plasma is easily collected and mostly contains some vital
biomarkers generated by cancers [10, 15, 21, 22]. Rekha
et al. [21] reported that the plasma Raman spectra of the
oral premalignant and malignant conditions were differ-
ent from the normal condition, and could be utilized to
diagnose the oral premalignant and malignant condi-
tions with the sensitivity and specificity of above 80.0%.
Serum Raman spectroscopy had the potential not only
in the diagnosis of oral cancers, but also in the predic-
tion of treatment responses [22]. Accordingly, the serum
was the sample of the choice in this study. The SERS
has been employed to detect and diagnose the cancers
with a high accuracy in different sites. High-quality SERS
of serum was used to identify the colorectal cancer with
the diagnostic accuracy of 100% [15]. The SERS in this
study successfully made the serum constituents adsorb
on the nanoparticles and captured the biomolecular
spectra fingerprints of the biomarkers.
In this study, the spectral differences of the peaks
assigned to various biomolecular fingerprints were cap-
tured in the SERS. Compared with the normal control
group, the spectra of OSCC and MEC group exhibited
the increasing intensities of the peaks at the 446 ~ 476,
548,726,745,1371 and 1445 cm−1. These peaks were
assigned to the nucleic acids and proteins which could
be caused by the active metabolism of nucleic acids in
the patients with cancers [10, 22]. These findings were
similar to the results reported in the previous studies.
Rekha et al. [21] and Sahu et al. [22] all found that the
increasing intensities of peaks at 1339 and 1445 cm−1
were related to the increase of the nucleic acids and pro-
teins in the plasma and serum of the oral cancer groups.
But in their reported studies, the ranges of Raman shifts
were limited from the 700 cm−1 or 800 cm−1 to 180 cm
−1, and the only routine Raman spectra were obtained,
so there were some differences between their results and
ours. Feng et al. [23] reported that the SERS band at
Table 2 Raman shifts of peaks and the characteristic
assignments
Raman shift (cm−1) Peak assignment
294 Au-S band
446–476 Cholesterol
548 S-S disulfide stretching in Proteins
726 Hypoxanthine
745 Thymine in DNA
933 C-C stretching mode, C-C αhelix in proteins
1136–1139 C-N stretch in D-mannons
1263 CH bending in lipids
1328 CH vibration in DNA/RNA, CH2 twisting in lipids
1371 Guanine in DNA, Tryptophan in proteins
1445 CH2, CH3 bending in proteins and lipids
1491 CH2 bending
1541–1542 C-N stretching, Amide II
1602–1607 C = C band in Phenylalanine or Tyrosine
Table 3 The results of the classification of OSCC and normal group
Class Predicted group Total
OSCC Normal
Count(%) OSCC 109(80.7%) 26(19.3%) 135(100%)
Normal 23(15.9%) 122(84.1%) 145(100%)
Fig. 5 The histogram of discrimination scores of OSCC and
normal group
Table 4 The results of the cross validation of OSCC and normal
group
Class Predicted group Total
OSCC Normal
Count(%) OSCC 107(79.3%) 28(20.7%) 135(100%)
Normal 25(17.2%) 120(82.8%) 145(100%)
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725 cm−1 were greater in nasopharyngeal cancer plasma
than the ones in the normal plasma, and the band was
assigned to the nucleic acids. The increasing proteins in
the serum of OSCC and MEC could result from the
redistribution or translocation of free amino acids in the
blood of the patients with cancers [24]. Compared with
the MEC group, there were the increasing intensities of
peaks at 1139, 1263,1491 cm−1 and the decreasing inten-
sity of peak at 1602 cm−1 in the SERS of OSCC group.
These differences demonstrated the higher D-mannos
and lipids level in the OSCC group. The previous study
reported that there was an alteration in plasma lipid
constituents in cancer patients because the cancer cells
would utilize lipids for new membrane biogenesis [25].
So all above spectral differences captured in the SERS
could be employed as the diagnostic indicators and ref-
erences to detect the OSCC serum samples.
In order to develop and establish the classification and
diagnostic models, numerous algorithms were employed
to analyze Raman spectral data in the reported studies
[21, 26–28]. Among these algorithms, PCA was a statis-
tical technique for reducing the dimensions and simpli-
fying complex data sets with the minimum
reconstruction error [29]. However, PCA was not suit-
able for classification problems because it could not use
any class information in computing the features ex-
tracted from the original data [30]. So Belhumeur et al.
[31] combined PCA with LDA to make a popular
method for dimension reduction and classification of
data sets. LDA was a well-known method which found a
linear transformation such that feature clusters were
most seperable after the transformation [29]. The PCA
combined with LDA were employed to classify and diag-
nose the different disease successfully based on the Ra-
man spectral features [18, 23, 26, 32]. Rekha et al. [21]
used PCA-LDA to yield a diagnostic sensitivity of 91.2%
and a specificity of 96.7% in the classification of normal
from oral malignant group. In this study, the PCA-LDA
could also successfully classify and diagnose the spectra
of OSCC and normal group with a sensitivity of 80.7%
and a specificity of 84.1%. The results of the cross valid-
ation demonstrated the utilization of the PCA-LDA al-
gorithm in the analysis of Raman spectral data was
reliable. Then PCA-LDA had an excellent performance
in the analysis and classification of the spectra of the
OSCC, MEC and normal groups with a total accuracy of
68.9%, which showed a giant potential to diagnose
OSCC based on the SERS.
Conclusion
The gold NPs were appropriate substances to capture
the high-quality surface enhanced Raman spectra of the
OSCC, MEC and normal serum samples. In these
Raman spectra, there were differences assigned to some
specific molecular structures and components, which
reflect the different levels of nucleic acids, proteins and
lipids in the cancers and normal serums. These differ-
ences might result from the metabolic alterations, cell
proliferation and apoptosis in the cancer serum. Based
on these spectral differences and features, PCA-LDA
could classify and diagnose the OSCC, MEC and normal
groups successfully. In a conclusion, SERS combined
PCA-LDA had a giant capability to detect and diagnosis
OSCC through the serum sample successfully.
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